title: Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy.
authors.forename: Sundararaman
authors.initials: S
authors.lastname: Swaminathan
authors.forename: Iftikhar
authors.initials: I
authors.lastname: Ahmed
authors.forename: James T
authors.initials: JT
authors.lastname: McCarthy
authors.forename: Robert C
authors.initials: RC
authors.lastname: Albright
authors.forename: Mark R
authors.initials: MR
authors.lastname: Pittelkow
authors.forename: Noel M
authors.initials: NM
authors.lastname: Caplice
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Griffin
authors.forename: Nelson
authors.initials: N
authors.lastname: Leung
mesh_terms: D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D005355:Fibrosis / Q000209:etiology; D006801:Humans; D011994:Recombinant Proteins; D051437:Renal Insufficiency / Q000150:complications*; D012871:Skin Diseases / Q000209:etiology* / Q000473:pathology*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin